Elizabeth C. Dees, MD
UNC Lineberger Comprehensive Cancer Center
5
4
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+12 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Robert Z. Orlowski, MD, PhD
UNC Lineberger Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Julie R. Gralow, MD
Seattle Cancer Care Alliance
Shared therapeutic areas:
Worked with same sponsors:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Steven A. Rosenberg, MD, PhD
NCI - Surgery Branch
Shared therapeutic areas:
Worked with same sponsors:
Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
Worked with same sponsors:
Alexander H Paterson, MD, FRCP
Tom Baker Cancer Centre - Calgary
Shared therapeutic areas:
Worked with same sponsors:
Robert B. Livingston, MD
University of Arizona
Shared therapeutic areas:
Worked with same sponsors:
Thomas E. Stinchcombe, MD
UNC Lineberger Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Carla I. Falkson, MD
University of Alabama at Birmingham
Shared therapeutic areas:
Worked with same sponsors:
Mark J. Clemons, MD
Toronto Sunnybrook Regional Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors
All 5 trials loaded